The J&J Vaccine is not Necessarily the Solution to SA’s Covid Problem

With the gatslag of the announcement that the AstraZeneca vaccine does not work against the SA variant, the health department seems to favour the J&J vaccine since its SA trial leg encountered the SA variant which none of the others did.  However, when you unpack the numbers, it is not hopeful as the effective sample size is exceedingly small.  I posit, with good reason, that the effective sample size on which they base their unimpressive efficacy of 57% is 49!

Continue reading